In this issue:
Efficacy and safety of upadacitinib
Changes in biologic use during pregnancy
Subcutaneous tocilizumab in Chinese rheumatoid arthritis patients
First-line biological DMARD therapy versus conventional synthetic DMARD therapy
Autoimmune disease-specific adverse events from CAR T-cell therapy
Tolerability, safety and efficacy of GSK3858279
Increasing age and number of lesions in sacroiliac joints
Anakinra for GCA patients
Tofacitinib for Takayasu arteritis
Methotrexate compared to prednisone
Please login below to download this issue (PDF)